References
- GabrielliAAvvedimentoEVKriegTSclerodermaN Engl J Med20093601989200319420368
- GalluccioFMatucci-CerinicMTwo faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosisAutoimmun Rev20111024124320863907
- LeRoyECMedsgerTARaynaud’s phenomenon: a proposal for classificationClin Exp Rheumatol1992104854881458701
- HerrickALPathogenesis of Raynaud’s phenomenonRheumatology20054458759615741200
- Kowal-BieleckaOLandewéRAvouacJEUSTAR Co-AuthorsEULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)Ann Rheum Dis20096862062819147617
- Della BellaSMolteniMCompassoSZulianCVanoliMScorzaRDifferential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytesProstaglandins Leukot Essent Fatty Acids1997561771849089795
- ScorzaRCaronniMMascagniBEffects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud’s phenomenon. A randomized, controlled studyClin Exp Rheumatol20011950350811579708
- GrantSMGoaKLIloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation proceduresDrugs1992438899241379160
- WigleyFMSeiboldJRWiseRAMcCloskeyDADoleWPIntravenous iloprost treatment of Raynaud’s phenomenon and ischemic ulcers secondary to systemic sclerosisJ Rheumatol199219140714141279170
- WigleyFMWiseRASeiboldJRIntravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyAnn Intern Med19941201992067506013
- CaramaschiPDalla GassaAPratiDSevere vascular complications in patients affected by systemic sclerosis cyclically treated with iloprostRheumatol Int2012321933193821448643
- CaramaschiPMartinelliNVolpeAA score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprostClin Rheumatol20092880781319301062
- Italfarmaco S.p.AEndoprost (Iloprost Trometamol Solution for Infusion) [Package Insert]Milano ITItalfarmaco S.p.A2013
- HudsonMThombsBDSteeleRCanadian Scleroderma Research GroupQuality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditionsJ Rheumatol20093676877219228662
- FaggioliPSciasceraAGianiLMazzoneAUn nuovo device per la somministrazione di iloprost mediante pompa a siringa portatile: sicurezza, tollerabilità e gradimento [Iloprost infusion by a new device as a portable syringe pump: safety, tolerability and agreement]It J Med20126311314 Italian
- MazzoneAVezzoliMOttiniEMontagnaMMazzucchelliIDal CantonAA new method of iloprost administration without a peristaltic pumpCurr Ther Res200061452459